Chemo

DRUG2 trials

Sponsors

First Affiliated Hospital Xi'an Jiaotong University, LARKSPUR BIOSCIENCES, INC.

Conditions

NeoplasmsTriple Negative Breast Neoplasms

Phase 1

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

RecruitingNCT07498725

LARKSPUR BIOSCIENCES, INC.Neoplasms

Start: 2026-07-07End: 2029-06-01Target: 120Updated: 2026-07-13

Phase 2

The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer

WithdrawnNCT02539017

First Affiliated Hospital Xi'an Jiaotong UniversityTriple Negative Breast Neoplasms

Start: 2015-11-30Updated: 2016-08-10